Princeton Capital Management LLC Bristol Myers Squibb CO Transaction History

Princeton Capital Management LLC

$313 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $32,401 - $42,656	-805 Reduced 11.51%	6,187 $256,000
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $32,050 - $36,339	-668 Reduced 8.72%	6,992 $379,000
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $56,818 - $67,800	-1,172 Reduced 13.27%	7,660 $393,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $140,441 - $157,034	-2,426 Reduced 21.55%	8,832 $512,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $54,026 - $59,987	-848 Reduced 7.0%	11,258 $719,000
Q1 2023 May 01, 2023	SELL	$65.71 - $74.53 $1.88 Million - $2.13 Million	-28,560 Reduced 70.23%	12,106 $839,000
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $370,819 - $439,102	-5,415 Reduced 11.75%	40,666 $2.93 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $95 - $56,707	-738 Reduced 1.58%	46,081 $3.28 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $1.25 Million - $1.37 Million	-17,175 Reduced 26.84%	46,819 $3.61 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $6,516 - $7,814	106 Added 0.17%	63,994 $4.67 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $67,841 - $79,087	-1,265 Reduced 1.94%	63,888 $3.98 Million
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $26,744 - $31,328	-452 Reduced 0.69%	65,153 $3.86 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $20,554 - $22,383	332 Added 0.51%	65,605 $4.38 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $74,293 - $83,558	-1,252 Reduced 1.88%	65,273 $4.12 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $173,046 - $196,093	2,997 Added 4.72%	66,525 $4.13 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $125,427 - $138,989	2,184 Added 3.56%	63,528 $3.83 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $102,513 - $119,848	1,870 Added 3.14%	61,344 $3.61 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $111,963 - $162,708	2,413 Added 4.23%	59,474 $3.64 Million
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $6,840 - $8,922	139 Added 0.24%	57,061 $3.78 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $37,979 - $45,030	-888 Reduced 1.54%	56,922 $2.89 Million
Q2 2019 Aug 12, 2019	SELL	$44.62 - $49.34 $115,208 - $127,395	-2,582 Reduced 4.28%	57,810 $2.62 Million
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $64,295 - $76,665	1,425 Added 2.42%	60,392 $2.88 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $1.57 Million - $2.04 Million	-32,227 Reduced 35.34%	58,967 $3.07 Million
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $1.58 Million - $1.78 Million	-28,545 Reduced 23.84%	91,194 $5.66 Million
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $58,917 - $73,434	-1,166 Reduced 0.96%	119,739 $6.63 Million
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $443,707 - $510,796	-7,405 Reduced 5.77%	120,905 $7.65 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $7.69 Million - $8.39 Million	128,310	128,310 $7.86 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.

Account